相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Next-generation influenza vaccines: opportunities and challenges
Chih-Jen Wei et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project
John Paget et al.
JOURNAL OF GLOBAL HEALTH (2019)
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance
Yao-Qing Chen et al.
JOURNAL OF VIROLOGY (2019)
Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017
Christopher E. Troeger et al.
LANCET RESPIRATORY MEDICINE (2019)
Drugs for Influenza Treatment: Is There Significant News?
Nicola Principi et al.
FRONTIERS IN MEDICINE (2019)
The human antibody response to influenza A virus infection and vaccination
Florian Krammer
NATURE REVIEWS IMMUNOLOGY (2019)
Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness
Melissa A. Rolfes et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype
Lisa Walz et al.
JOURNAL OF VIROLOGY (2018)
NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
Florian Krammer et al.
MBIO (2018)
Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
Daniela S. Rajao et al.
FRONTIERS IN MICROBIOLOGY (2018)
Efforts to Improve the Seasonal Influenza Vaccine
Alfred T. Harding et al.
VACCINES (2018)
Recombinant Adenoviruses Displaying Matrix 2 Ectodomain Epitopes on Their Fiber Proteins as Universal Influenza Vaccines
Xinying Tang et al.
JOURNAL OF VIROLOGY (2017)
Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs
Alfred T. Harding et al.
MBIO (2017)
Universal influenza virus vaccines and therapeutic antibodies
R. Nachbagauer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
Karlynn E. Neu et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments
Amir Mehdi Ansari et al.
STEM CELL REVIEWS AND REPORTS (2016)
Development and applications of single-cycle infectious influenza A virus (sciIAV)
Aitor Nogales et al.
VIRUS RESEARCH (2016)
Influenza A Virus Hemagglutinin is Required for the Assembly of Viral Components Including Bundled vRNPs at the Lipid Raft
Naoki Takizawa et al.
VIRUSES-BASEL (2016)
Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments
Amir Mehdi Ansari et al.
STEM CELL REVIEWS AND REPORTS (2016)
Influenza Vaccines: Challenges and Solutions
Katherine Houser et al.
CELL HOST & MICROBE (2015)
Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses
Wen-Chun Liu et al.
JOURNAL OF VIROLOGY (2015)
Advances in the development of influenza virus vaccines
Florian Krammer et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
Teddy John Wohlbold et al.
MBIO (2015)
Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
Robert B. Couch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
In Vivo Bioluminescent Imaging of Influenza A Virus Infection and Characterization of Novel Cross-Protective Monoclonal Antibodies
Nicholas S. Heaton et al.
JOURNAL OF VIROLOGY (2013)
Protection against Lethal Influenza with a Viral Mimic
Steven F. Baker et al.
JOURNAL OF VIROLOGY (2013)
Virus-like Particles Containing Multiple M2 Extracellular Domains Confer Improved Cross-protection Against Various Subtypes of Influenza Virus
Min-Chul Kim et al.
MOLECULAR THERAPY (2013)
Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity
Timothy J. Powell et al.
JOURNAL OF VIROLOGY (2012)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure
Diana L. Noah et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Xiaocong Yu et al.
NATURE (2008)
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Xiao-Song He et al.
JOURNAL OF VIROLOGY (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design
WL Liu et al.
MICROBES AND INFECTION (2005)
分享论文
